Equillium Total Liab vs Current Deferred Revenue Analysis

EQ Stock

USD 1.56 0.02 1.30%

Equillium financial indicator trend analysis is much more than just examining Equillium latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Equillium is a good investment. Please check the relationship between Equillium Total Liab and its Current Deferred Revenue accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.

To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.

Total Liab vs Current Deferred Revenue

Total Liab vs Current Deferred Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Equillium Total Liab account and Current Deferred Revenue. At this time, the significance of the direction appears to have weak relationship.

The correlation between Equillium's Total Liab and Current Deferred Revenue is 0.31. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Current Deferred Revenue in the same time period over historical financial statements of Equillium, assuming nothing else is changed. The correlation between historical values of Equillium's Total Liab and Current Deferred Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Equillium are associated (or correlated) with its Current Deferred Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Deferred Revenue has no effect on the direction of Total Liab i.e., Equillium's Total Liab and Current Deferred Revenue go up and down completely randomly.

Correlation Coefficient

0.31

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most indicators from Equillium's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Equillium current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.

To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.As of 05/18/2024, Selling General Administrative is likely to drop to about 10.3 M. In addition to that, Tax Provision is likely to drop to about 319 K

	2021	2022	2023	2024 (projected)
Other Operating Expenses	37.8M	54.8M	50.6M	38.1M
Depreciation And Amortization	72K	46.1M	126K	119.7K

Other Operating Expenses Depreciation And Amortization

Equillium fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		-0.22	0.31	0.62	0.92	0.57	0.96	0.71	-0.87	-0.73	0.55	0.86	0.71	0.07	-0.38	1.0	0.9	0.58	0.65	-0.19	0.9	0.96	0.9	0.55	0.76	0.68
Short Long Term Debt Total	-0.22		-0.52	-0.38	-0.16	-0.34	-0.34	-0.08	0.21	0.36	0.03	-0.08	-0.1	-0.25	0.64	-0.2	-0.21	-0.12	-0.66	0.97	-0.25	-0.09	-0.27	0.06	-0.27	-0.17
Other Current Liab	0.31	-0.52		0.2	0.3	0.41	0.46	0.33	-0.09	-0.37	-0.37	0.05	0.34	0.06	0.14	0.3	0.37	0.25	0.5	-0.67	0.36	0.28	0.34	-0.13	0.06	0.39
Total Current Liabilities	0.62	-0.38	0.2		0.29	0.9	0.46	0.75	-0.74	-0.97	0.81	0.73	0.76	0.39	-0.45	0.58	0.77	0.89	0.61	-0.25	0.78	0.71	0.84	0.89	0.29	0.78
Total Stockholder Equity	0.92	-0.16	0.3	0.29		0.27	0.96	0.51	-0.71	-0.44	0.27	0.68	0.51	-0.08	-0.34	0.94	0.75	0.3	0.56	-0.19	0.75	0.82	0.72	0.24	0.8	0.47
Other Liab	0.57	-0.34	0.41	0.9	0.27		0.44	0.9	-0.75	-0.93	0.61	0.75	0.9	0.63	-0.31	0.53	0.73	0.92	0.56	-0.27	0.76	0.64	0.81	0.77	0.02	0.91
Net Tangible Assets	0.96	-0.34	0.46	0.46	0.96	0.44		0.58	-0.75	-0.6	0.31	0.72	0.58	0.0	-0.37	0.96	0.82	0.41	0.69	-0.37	0.82	0.87	0.8	0.31	0.79	0.56
Property Plant And Equipment Net	0.71	-0.08	0.33	0.75	0.51	0.9	0.58		-0.86	-0.85	0.59	0.87	1.0	0.57	-0.27	0.67	0.84	0.91	0.47	-0.03	0.87	0.76	0.87	0.76	0.11	0.99
Net Debt	-0.87	0.21	-0.09	-0.74	-0.71	-0.75	-0.75	-0.86		0.79	-0.73	-0.99	-0.85	-0.49	0.59	-0.85	-0.83	-0.73	-0.55	0.11	-0.87	-0.83	-0.89	-0.72	-0.46	-0.82
Retained Earnings	-0.73	0.36	-0.37	-0.97	-0.44	-0.93	-0.6	-0.85	0.79		-0.72	-0.78	-0.86	-0.37	0.37	-0.69	-0.88	-0.93	-0.66	0.28	-0.89	-0.81	-0.93	-0.85	-0.33	-0.88
Accounts Payable	0.55	0.03	-0.37	0.81	0.27	0.61	0.31	0.59	-0.73	-0.72		0.76	0.59	0.28	-0.48	0.52	0.62	0.72	0.32	0.22	0.63	0.64	0.69	0.93	0.36	0.57
Cash	0.86	-0.08	0.05	0.73	0.68	0.75	0.72	0.87	-0.99	-0.78	0.76		0.86	0.47	-0.46	0.84	0.81	0.74	0.47	0.03	0.84	0.84	0.87	0.76	0.42	0.82
Non Current Assets Total	0.71	-0.1	0.34	0.76	0.51	0.9	0.58	1.0	-0.85	-0.86	0.59	0.86		0.56	-0.27	0.67	0.85	0.92	0.49	-0.05	0.87	0.76	0.88	0.76	0.12	0.99
Non Currrent Assets Other	0.07	-0.25	0.06	0.39	-0.08	0.63	0.0	0.57	-0.49	-0.37	0.28	0.47	0.56		-0.41	0.05	0.12	0.43	0.26	-0.16	0.22	0.03	0.25	0.32	-0.43	0.56
Long Term Debt	-0.38	0.64	0.14	-0.45	-0.34	-0.31	-0.37	-0.27	0.59	0.37	-0.48	-0.46	-0.27	-0.41		-0.36	-0.35	-0.27	-0.54	0.48	-0.42	-0.25	-0.44	-0.3	-0.42	-0.3
Cash And Short Term Investments	1.0	-0.2	0.3	0.58	0.94	0.53	0.96	0.67	-0.85	-0.69	0.52	0.84	0.67	0.05	-0.36		0.87	0.53	0.62	-0.18	0.87	0.95	0.87	0.51	0.77	0.63
Common Stock Total Equity	0.9	-0.21	0.37	0.77	0.75	0.73	0.82	0.84	-0.83	-0.88	0.62	0.81	0.85	0.12	-0.35	0.87		0.83	0.63	-0.18	0.99	0.94	0.98	0.73	0.57	0.85
Common Stock Shares Outstanding	0.58	-0.12	0.25	0.89	0.3	0.92	0.41	0.91	-0.73	-0.93	0.72	0.74	0.92	0.43	-0.27	0.53	0.83		0.46	-0.03	0.84	0.71	0.86	0.91	0.1	0.94
Long Term Debt Total	0.65	-0.66	0.5	0.61	0.56	0.56	0.69	0.47	-0.55	-0.66	0.32	0.47	0.49	0.26	-0.54	0.62	0.63	0.46		-0.64	0.69	0.61	0.7	0.34	0.53	0.53
Non Current Liabilities Total	-0.19	0.97	-0.67	-0.25	-0.19	-0.27	-0.37	-0.03	0.11	0.28	0.22	0.03	-0.05	-0.16	0.48	-0.18	-0.18	-0.03	-0.64		-0.21	-0.06	-0.22	0.2	-0.24	-0.12
Capital Surpluse	0.9	-0.25	0.36	0.78	0.75	0.76	0.82	0.87	-0.87	-0.89	0.63	0.84	0.87	0.22	-0.42	0.87	0.99	0.84	0.69	-0.21		0.93	0.99	0.74	0.55	0.88
Other Current Assets	0.96	-0.09	0.28	0.71	0.82	0.64	0.87	0.76	-0.83	-0.81	0.64	0.84	0.76	0.03	-0.25	0.95	0.94	0.71	0.61	-0.06	0.93		0.94	0.7	0.69	0.74
Other Stockholder Equity	0.9	-0.27	0.34	0.84	0.72	0.81	0.8	0.87	-0.89	-0.93	0.69	0.87	0.88	0.25	-0.44	0.87	0.98	0.86	0.7	-0.22	0.99	0.94		0.78	0.54	0.88
Total Liab	0.55	0.06	-0.13	0.89	0.24	0.77	0.31	0.76	-0.72	-0.85	0.93	0.76	0.76	0.32	-0.3	0.51	0.73	0.91	0.34	0.2	0.74	0.7	0.78		0.21	0.76
Net Invested Capital	0.76	-0.27	0.06	0.29	0.8	0.02	0.79	0.11	-0.46	-0.33	0.36	0.42	0.12	-0.43	-0.42	0.77	0.57	0.1	0.53	-0.24	0.55	0.69	0.54	0.21		0.1
Property Plant And Equipment Gross	0.68	-0.17	0.39	0.78	0.47	0.91	0.56	0.99	-0.82	-0.88	0.57	0.82	0.99	0.56	-0.3	0.63	0.85	0.94	0.53	-0.12	0.88	0.74	0.88	0.76	0.1

Click cells to compare fundamentals

Equillium Account Relationship Matchups

Equillium fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	55.5M	85.4M	85.4M	78.4M	50.5M	67.5M
Short Long Term Debt Total	9.7M	8.3M	10.0M	10.2M	824K	782.8K
Other Current Liab	2.0M	2.8M	5.9M	(6.1M)	6.7M	7.0M
Total Current Liabilities	3.9M	7.2M	8.9M	32.0M	27.6M	29.0M
Total Stockholder Equity	41.8M	69.9M	66.5M	31.9M	22.6M	21.4M
Other Liab	200K	127K	54K	10.4M	11.9M	12.5M
Net Tangible Assets	41.8M	69.9M	66.5M	31.9M	36.7M	50.0M
Property Plant And Equipment Net	93K	239K	1.6M	1.2M	1.1M	682.7K
Net Debt	(3.5M)	(15.7M)	(40.4M)	(48.9M)	(22.4M)	(23.5M)
Retained Earnings	(41.1M)	(70.9M)	(110.0M)	(172.4M)	(185.7M)	(176.5M)
Accounts Payable	1.9M	2.8M	1.2M	17.3M	4.7M	4.6M
Cash	13.2M	24.0M	50.4M	59.1M	23.2M	32.3M
Non Current Assets Total	108K	254K	1.6M	1.2M	1.2M	698.4K
Non Currrent Assets Other	(93K)	(239K)	153K	104K	70K	73.5K
Long Term Debt	9.7M	8.3M	8.8M	3.2M	3.7M	7.0M
Cash And Short Term Investments	53.1M	82.2M	80.7M	71.0M	40.9M	63.0M
Common Stock Shares Outstanding	17.4M	20.4M	28.8M	33.7M	34.7M	25.8M
Short Term Investments	39.9M	58.2M	30.3M	11.9M	17.7M	22.3M
Liabilities And Stockholders Equity	55.5M	85.4M	85.4M	78.4M	50.5M	67.5M
Non Current Liabilities Total	9.8M	8.3M	10.0M	14.4M	384K	364.8K
Capital Surpluse	80.4M	82.9M	141.1M	176.6M	203.1M	105.8M
Other Current Assets	2.4M	3.3M	3.0M	3.4M	2.2M	2.4M
Other Stockholder Equity	82.9M	141.1M	176.6M	204.3M	208.2M	140.4M
Total Liab	13.7M	15.6M	18.9M	46.5M	28.0M	21.1M
Net Invested Capital	51.5M	79.8M	8.8M	40.9M	22.6M	31.3M
Property Plant And Equipment Gross	93K	239K	1.6M	1.2M	1.5M	739.9K
Total Current Assets	55.5M	85.4M	83.8M	77.2M	49.3M	66.9M
Accumulated Other Comprehensive Income	21K	(297K)	(138K)	76K	140K	147K
Non Current Liabilities Other	127K	54K	1.2M	4.1M	4.7M	4.9M
Net Working Capital	51.5M	77.9M	74.8M	44.7M	21.8M	20.7M
Common Stock	789.0	1K	2K	3K	3.5K	1.9K
Property Plant Equipment	93K	239K	237K	1.6M	1.8M	1.9M
Other Assets	(108K)	(254K)	153K	3.4M	1.0	0.95

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Equillium is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Equillium Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Equillium Stock. Highlighted below are key reports to facilitate an investment decision about Equillium Stock:

How To Invest In Equillium

Details

Is Equillium Stock a good investment?

Details

What is Equillium's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Equillium. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.

To learn how to invest in Equillium Stock, please use our How to Invest in Equillium guide.

You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Equillium Stock analysis

When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.

	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities

Is Equillium's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Equillium. If investors know Equillium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Equillium listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.35)

Revenue Per Share

1.085

Quarterly Revenue Growth

0.204

Return On Assets

(0.14)

Return On Equity

(0.48)

The market value of Equillium is measured differently than its book value, which is the value of Equillium that is recorded on the company's balance sheet. Investors also form their own opinion of Equillium's value that differs from its market value or its book value, called intrinsic value, which is Equillium's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Equillium's market value can be influenced by many factors that don't directly affect Equillium's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Equillium's value and its price as these two are different measures arrived at by different means. Investors typically determine if Equillium is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Equillium's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Equillium Total Liab vs Current Deferred Revenue Analysis

Total Liab vs Current Deferred Revenue

Total Liab vs Current Deferred Revenue Correlation Analysis

Correlation Coefficient

Total Liab

Current Deferred Revenue

Equillium fundamental ratios Correlations

Equillium Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Equillium fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Equillium Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total
Capital Surpluse	+ 0.99	Common Stock Total Equity
Other Stockholder Equity	+ 0.99	Capital Surpluse

Cash	- 0.99	Net Debt
Retained Earnings	- 0.97	Total Current Liabilities
Other Stockholder Equity	- 0.93	Retained Earnings
Common Stock Shares Outstanding	- 0.93	Retained Earnings
Retained Earnings	- 0.93	Other Liab
Capital Surpluse	- 0.89	Retained Earnings